Wellington, New Zealand Clinical Trials

Adenocarcinoma

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study of Pembroliziumab and Paclitaxel for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (MK-3475-061/KEYNOTE-061)

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial to evaluate treatments using Pembrolizumab, Cisplatin, 5-FU and Capecitabine for patients with Gastric Adenocarcinoma. Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

AIDS and AIDS related infections

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Alzheimer's Disease

Anemia

CCDHB - Wellington Hospital Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Arthritis and Arthritic Pain

Site Reference ID/Investigator# 136628 Updated

Patients are needed to participate in a clinical research study evaluating adalimumab and ABT-122 for the treatment of Psoriatic Arthritis

Wellington Hospital, Capital and Coast District Health Board Updated

A clinical trial to evaluate treatments using PF-06410293 and Adalimumab for patients with Rheumatoid Arthritis (REFLECTIONS B538-02)

Wellington Hospital, Clinical Trial Unit, Level 8

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Asthma

Research Site

Patients are needed to participate in a clinical research study evaluating budesonide/formoterol 'as needed' + budesonide placebo bid and budesonode bid + terbutaline 'as needed' for the treatment of Asthma

Atherosclerosis

Research Site

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Atopic Dermatitis

Research Site

Patients are needed to participate in a clinical research study of MEDI9929 and Placebo to evaluate Atopic Dermatitis

Atrial Fibrillation

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Bladder Cancer

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

Breast Cancer

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial to evaluate treatments using Pembrolizumab for patients with Breast Cancer, Triple-Negative Breast Cancer

COPD (Chronic Obstructive Pulmonary Disease)

Research Site

A clinical research study of Flutiform 500/20 µg BID, Flutiform 250/10 µg BID and Seretide Accuhaler 50/500 µg BID for the treatment of Chronic Obstructive Pulmonary Disease

GSK Investigational Site Updated

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Medical Research Institute of New Zealand

A clinical trial to evaluate treatments using NHF with Oxygen using myAIRVO™ 2 and NHF without Oxygen using myAIRVO™ 2 for patients with Chronic Obstructive Pulmonary Disease or COPD, COPD Exacerbation

Crohn's Disease

Capital and Coast District Health board-Wellington hospital

A clinical trial to evaluate treatments using GS-5745 and Placebo for patients with Crohn's Disease

Site Reference ID/Investigator# 133295 Updated

A clinical trial to evaluate treatments using ABT-494 and Placebo for patients with Crohn's Disease

Site Reference ID/Investigator# 141721

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Deep Vein Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Dermatitis, Atopic

Research Site

Patients are needed to participate in a clinical research study of MEDI9929 and Placebo to evaluate Atopic Dermatitis

Diabetes Mellitus, Type 2

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial seeking patients for a research study for the treatment of Diabetes Mellitus, Type 2

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study for the treatment of Type 2 Diabetes Mellitus (T2DM)

Fibromyalgia

Research Site Updated

A Phase 3 clinical study for patients with Pain Associated With Fibromyalgia

Gastric Cancer

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial to evaluate treatments using Pembrolizumab, Cisplatin, 5-FU and Capecitabine for patients with Gastric Adenocarcinoma. Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study of Pembroliziumab and Paclitaxel for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (MK-3475-061/KEYNOTE-061)

Glaucoma

Research Site

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Heart Attack (Myocardial Infarction)

Wellington Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Wellington Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Heart Failure

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Hepatitis

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study of Grazoprevir, MK-3682, Elbasvir and MK-8408 to evaluate Hepatitis C Virus (HCV)

Site Reference ID/Investigator# 130916 Updated

Patients are needed to participate in a clinical research study evaluating ABT-493, ABT-530 and Ribavirin (RBV) for the treatment of Chronic Hepatitis C Virus (HCV)

High Blood Pressure (Hypertension)

Research Site

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

High Cholesterol (Hyperlipidemia)

Wellington Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Wellington Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

HIV Infections

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Hypertriglyceridemia

Research Site

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Kidney Disease

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Lung Disease

Research Site

A clinical research study of Flutiform 500/20 µg BID, Flutiform 250/10 µg BID and Seretide Accuhaler 50/500 µg BID for the treatment of Chronic Obstructive Pulmonary Disease

GSK Investigational Site Updated

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Lung Injury

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Lupus

GSK Investigational Site Updated

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Lymphocytic Leukemia, Chronic

Research Site Updated

A clinical trial to evaluate treatments using Chlorambucil, GDC-0199 and Obinutuzumab for patients with Chronic Lymphocytic Leukemia

Melanoma

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating Pembrolizumab and placebo for the treatment of Melanoma, High-Risk Stage III Melanoma (MK-3475-054/KEYNOTE-054)

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A Phase 1/Phase 2 clinical study for patients with Melanoma

Multiple Sclerosis

P3 Research

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Myelofibrosis

CCDHB - Wellington Hospital Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Neoplasm Metastasis

1160.189.64201 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

P3 Research

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Neoplasms

Research Site

A clinical research study of Trabectedin, DOXIL and Dexamethasone for the treatment of Ovarian Neoplasms, Peritoneal Neoplasms or Fallopian Tube Neoplasms

Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 125755

Patients are needed to participate in a clinical research study of veliparib, carboplatin, paclitaxel and placebo to evaluate Squamous Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 132470

Patients are needed to participate in a clinical research study to evaluate Non-squamous Non-small Cell Lung Cancer

Ocular Hypertension

Research Site

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Osteoporosis

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A Phase 1 clinical study for patients with Osteoporosis

Pain

Research Site Updated

A Phase 3 clinical study for patients with Pain Associated With Fibromyalgia

Pneumonia

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating TR-701 FA IV and Linezolid for the treatment of Pneumonia

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Psoriatic Arthritis

Site Reference ID/Investigator# 136628 Updated

Patients are needed to participate in a clinical research study evaluating adalimumab and ABT-122 for the treatment of Psoriatic Arthritis

Pulmonary Embolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Rheumatoid Arthritis

Site Reference ID/Investigator# 141721

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Wellington Hospital, Capital and Coast District Health Board Updated

A clinical trial to evaluate treatments using PF-06410293 and Adalimumab for patients with Rheumatoid Arthritis (REFLECTIONS B538-02)

Wellington Hospital, Clinical Trial Unit, Level 8

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Rosacea

Research Site

A Phase 3 clinical study for patients with Rosacea

Solid Tumors

Wellington Hospital

A clinical research study of BGB-283 for the treatment of Solid Tumors

Stroke

1160.189.64201 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Wellington Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Wellington Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Systemic Lupus Erythematosus

GSK Investigational Site Updated

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Thromboembolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ulcerative Colitis

Research Site

A Phase 2/Phase 3 clinical study for patients with Ulcerative Colitis, Moderate to Severe Active Ulcerative Colitis

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Ulcers

Research Site

A Phase 2/Phase 3 clinical study for patients with Ulcerative Colitis, Moderate to Severe Active Ulcerative Colitis

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Venous Thromboembolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Venous Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)